The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
Kampman
K M
KM
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. kampman@research.trc.upenn.edu
Rukstalis
M
M
Pettinati
H
H
Muller
E
E
Acosta
T
T
Gariti
P
P
Ehrman
R
R
O'Brien
C P
CP
D000328:Adult; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003042:Cocaine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005277:Fenfluramine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000009:adverse effects*; D010645:Phentermine / Q000627:therapeutic use*; D010865:Pilot Projects; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D003042:Cocaine; D005277:Fenfluramine; D009294:Narcotics; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors